In parallel, apelin-13 was able to inhibit the ROS-mediated inflammatory response of ischemic stroke by activating the phosphorylation level of AMP-activated protein kinase (AMPK) and the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) [116]. Here, NFE2L2 is linked to ischemic stroke.